512 related articles for article (PubMed ID: 21131794)
21. Health insurance status and hypertension monitoring and control in the United States.
Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
[TBL] [Abstract][Full Text] [Related]
22. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
23. Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey.
Sabatino SA; Thompson TD; Richardson LC; Miller J
Med Care; 2012 Mar; 50(3):270-6. PubMed ID: 22193416
[TBL] [Abstract][Full Text] [Related]
24. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
[TBL] [Abstract][Full Text] [Related]
25. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
26. Health services utilization in the U.S. population by health insurance coverage.
Garfinkel SA; Corder LS
Natl Med Care Util Expend Surv B; 1986 Dec; (13):1-38. PubMed ID: 10304187
[TBL] [Abstract][Full Text] [Related]
27. Association of insurance with cancer care utilization and outcomes.
Ward E; Halpern M; Schrag N; Cokkinides V; DeSantis C; Bandi P; Siegel R; Stewart A; Jemal A
CA Cancer J Clin; 2008; 58(1):9-31. PubMed ID: 18096863
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with immunotherapy use among newly diagnosed cancer patients.
Shih YC; Elting LS; Halpern MT
Med Care; 2009 Sep; 47(9):948-58. PubMed ID: 19704352
[TBL] [Abstract][Full Text] [Related]
29. Insurance status and the use of guideline therapy in the treatment of selected cancers.
Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
[TBL] [Abstract][Full Text] [Related]
30. Insurance status and distant-stage disease at diagnosis among adolescent and young adult patients with cancer aged 15 to 39 years: National Cancer Data Base, 2004 through 2010.
Robbins AS; Lerro CC; Barr RD
Cancer; 2014 Apr; 120(8):1212-9. PubMed ID: 24474656
[TBL] [Abstract][Full Text] [Related]
31. Uninsured and unstably insured: the importance of continuous insurance coverage.
Schoen C; DesRoches C
Health Serv Res; 2000 Apr; 35(1 Pt 2):187-206. PubMed ID: 10778809
[TBL] [Abstract][Full Text] [Related]
32. Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients.
Bradley CJ; Dahman B; Bear HD
Cancer; 2012 Oct; 118(20):5084-91. PubMed ID: 22415708
[TBL] [Abstract][Full Text] [Related]
33. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.
Fedewa SA; Etzioni R; Flanders WD; Jemal A; Ward EM
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2437-44. PubMed ID: 20705937
[TBL] [Abstract][Full Text] [Related]
34. Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?
Chase DM; Fedewa S; Chou TS; Chen A; Ward E; Brewster WR
Obstet Gynecol; 2012 Jan; 119(1):68-77. PubMed ID: 22183213
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
36. Supplemental health insurance coverage among aged Medicare beneficiaries.
Garfinkel SA; Corder LS
Natl Med Care Util Expend Surv B; 1985 Aug; (5):1-37. PubMed ID: 10304189
[TBL] [Abstract][Full Text] [Related]
37. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
38. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
39. Insurance status is related to diffuse large B-cell lymphoma survival.
Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
[TBL] [Abstract][Full Text] [Related]
40. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
Chen AY; Fedewa S; Zhu J
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
